POLYCYSTIC KIDNEY DISEASE
A Double-blind Randomized Parallel Group Study of the Efficacy and Safety of Tesevatinib in Subjects with Autosomal Dominant Polycystic Kidney Disease

A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Disease

Autosomal Dominant Polycystic Kidney Disease Data Repository

Clinical Care of Autosomal Dominant Polycystic Kidney Disease: Retrospective Analysis and Prospective PKD Genotyping

Pilot study of genetic changes with Autosomal Dominant Polycystic Kidney Disease

DIABETIC KIDNEY DISEASE
FInerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease FIDELIO-DKD

CHRONIC KIDNEY DISEASE
RENAL AID:  Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies


ANEMIA AND CHRONIC KIDNEY DISEASE
ASCEND-ND The Anemia Study in CKD: Erythropoiesis via a Novel PHI Daprodustat-Non-Dialysis

KIDNEY TRANSPLANTATION AND HYPERKALEMIA
Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients with Hyperkalemia Receiving Patiromer

FAMILIAL HYPERCHOLESTEROLEMIA 
The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository

CASCADE FH Registry

PANCREATIC CANCER
An Open-Label, Phase II Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Cell-Containing Agarose-Agarose Macrobeads in the Treatment of Patients with Treatment-Resistant, Metastatic Pancreatic Adenocarcinoma or Colorectal Cancer

COLORECTAL CANCER
A Phase IIb, Nonrandomized, Open-Label Trial with Mouse Renal Adenocarcinoma (RENCA) Cell Containing Agarose-Agarose Macrobeads Compared with Best Supportive Care in Patients with Treatment-Resistant, Metastatic Colorectal Carcinoma

 

For general information regarding the Clinical Research Program, please contact:
Betty-Jane Sloan, MA, CCRC, Clinical Research Manager
504 East 74th Street, 5th Floor
New York, NY  10021
Email: bjsloan@nyp.org
Phone:  646-317-0701